Search Orphan Drug Designations and Approvals
-
Generic Name: | Botulinum toxin type A |
---|---|
Date Designated: | 03/23/1989 |
Orphan Designation: | Treatment of essential blepharospasm. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Porton International, Inc. 1155 15th Street, N.W., #315 Washington, District of Columbia 20005 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-